GlassScriptPhysician profile
Erin Handspiker
NPI 1336712405
$2,121.45
in general payments reported to CMS, 2019-2025
12 companies · $437 in 2025
The $437 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,133 · 2023: $221 · 2024: $331 · 2025: $437.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $920 · Education: $68.49.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $920.20 |
| Education | $68.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $715.24 | 2022 | |
| Medical Device Business Services, INC. | $305.00 | 2022 | |
| Penumbra, INC. | $253.85 | 2024-2025 | Penumbra System, Indigo System |
| Medtronic, INC. | $214.45 | 2022-2025 | Endurant Iis, Signia |
| Haemonetics Corporation | $162.51 | 2022-2023 | Teg6s Hemostasis System |
| Boston Scientific Corporation | $117.32 | 2025 | Eluvia |
| Kci USA, INC. | $98.99 | 2023 | Prevena, Abthera, V.A.C. Veraflo |
| Ethicon US, LLC | $70.89 | 2022-2025 | Echelon Circular, Surgicel Nu-Knit |
| Astrazeneca Pharmaceuticals LP | $68.49 | 2025 | Imfinzi |
| Silk Road Medical, INC. | $49.08 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Lemaitre Vascular, INC. | $33.11 | 2023-2025 | Artegraft Vascular Graft |
| Shockwave Medical, INC | $32.52 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Handspiker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.